Jack Nathan Medical Corp. (JNH.V)

Jack Nathan Medical Corp. (JNH.V) — VMCI valuation read

JNH.V prints VMCI 50/100 inside the Healthcare sector, where the median sits at 50. The 0-point below-median delta is the cleanest single-number summary of Jack Nathan Medical Corp.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On JNH.V, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** JNH.V trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 2.0x is the rate-sensitivity line to watch; that is the risk line for Jack Nathan Medical Corp. on the trailing financials.

JNH.V rose 2.4% over the trailing 7 days, with a +1.2% read on a 30-day basis.